With Parion Deal Done, Shire CEO Looks To Next Bright Ophthalmic Innovation

 
• By Sten Stovall

Shire's CEO Flemming Ornskov says he's focused on the specialist pharma's emerging ophthalmics division - and open to fresh innovative collaborations like that signed this week with Parion Sciences.

Man's eyes
Shire has its eyes on ophthalmic expansion • Source: Shutterstock

More from Deals

More from Business